1 study on Innate repair receptor mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
These findings propose ARA-290 as a potential adjunctive therapy to mitigate the severe side effects of doxorubicin, a cornerstone of many cancer treatments. For patients undergoing chemotherapy, this could mean reduc…